| Literature DB >> 11036056 |
S J Kopytek1, J C Dyer, G S Knapp, J C Hu.
Abstract
Many laboratory strains of Escherichia coli are resistant to methotrexate (MTX), a folate analogue that binds dihydrofolate reductase (DHFR). Mutations that inactivate either tolC or acrA confer MTX sensitivity. Further, overexpression of a fusion protein with DHFR activity reverses this sensitivity by titrating out intracellular MTX. These results suggest that MTX accumulates in cells where mutations in acrA or tolC have inactivated the TolC-dependent AcrAB multidrug resistance efflux pump.Entities:
Mesh:
Substances:
Year: 2000 PMID: 11036056 PMCID: PMC101636 DOI: 10.1128/AAC.44.11.3210-3212.2000
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191